Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Danting Zhu"'
Autor:
Kurt de Vlam, Walter P. Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J. McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J. Bolce, Philip G. Conaghan
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 691-707 (2024)
Abstract Introduction The objective of this analysis is to evaluate the improvement in spinal pain with ixekizumab, placebo, and adalimumab based on objective measures of inflammation response in patients with ankylosing spondylitis (AS). Methods The
Externí odkaz:
https://doaj.org/article/eb8f53ffcf3f4cc2b2c455d755a35ab8
Autor:
Andreas Wollenberg, Masanori Ikeda, Chia-Yu Chu, Lawrence F. Eichenfield, Marieke M. B. Seyger, Apurva Prakash, Robinette Angle, Danting Zhu, Marco Pontes, Amy S. Paller
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Baricitinib, an oral selective Janus kinase inhibitor, improved clinical signs and symptoms of moderate-to-severe atopic dermatitis (AD) at week 16 in the phase 3 pediatric study BREEZE-AD-PEDS.Objective To assess longer-term efficacy and
Externí odkaz:
https://doaj.org/article/60c95020afe746ab9bb7dbef4c3fa42d
Autor:
Atul Deodhar, Andrew Blauvelt, Mark Lebwohl, Meghan Feely, Andris Kronbergs, Nadezhda Eberhart, Danting Zhu, Elsa Inman, Elsie Grace, Thorsten Holzkaemper, Proton Rahman, Helena Marzo-Ortega, Kim A. Papp, Joseph F. Merola, Alice B. Gottlieb, Sergio Schwartzman
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-16 (2024)
Abstract Background We report long-term, end-of-study program safety outcomes from 25 randomized clinical trials (RCTs) in adult patients with psoriasis (PsO), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA) [including ankylosing spondy
Externí odkaz:
https://doaj.org/article/1bc182a808cb4b8a907eae62f5ff0a85
Autor:
Kurt de Vlam, Walter P. Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J. McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J. Bolce, Philip G. Conaghan
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 1063-1063 (2024)
Externí odkaz:
https://doaj.org/article/f8ef4c01d90e4cb1a780a59d216f6584
Publikováno v:
Heliyon, Vol 9, Iss 3, Pp e13975- (2023)
Objectives: To investigate the role of AdipoRon in bone wound healing of calvaria critical-sized defects (CSD) in diet-induced obesity (DIO) mice. Materials and methods: After establishing the calvaria CSD in normal-chow (NC), DIO and Adiponectin kno
Externí odkaz:
https://doaj.org/article/8237bb34a8a24c60813e15649a84a879
Regular exercise attenuates alcoholic myopathy in zebrafish by modulating mitochondrial homeostasis.
Autor:
Wei Wen, Cheng Guo, Zhanglin Chen, Dong Yang, Danting Zhu, Quwen Jing, Lan Zheng, Chenchen Sun, Changfa Tang
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294700 (2023)
Alcoholic myopathy is caused by chronic consumption of alcohol (ethanol) and is characterized by weakness and atrophy of skeletal muscle. Regular exercise is one of the important ways to prevent or alleviate skeletal muscle myopathy. However, the ben
Externí odkaz:
https://doaj.org/article/9f588211a86449d4bfe2b65b28a895b5
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Periodontal abscess is an oral infective disease caused by various kinds of bacteria. We aimed to characterize the microbiota composition of periodontal abscesses by metagenomic methods and compare it to that of the corresponding pocket and healthy g
Externí odkaz:
https://doaj.org/article/6e8a30f561204ee09b0f10aac443b41d
Autor:
Atul Deodhar, Andrew Blauvelt, Sergio Schwartzman, Carlo Salvarani, Meghan Feely, Andris Kronbergs, Nadia Eberhart, Danting Zhu, Elsa Mevel, Thorsten Holzkaemper, Eswar Krishnan, Mark Lebwohl, Proton Rahman, Helena Marzo-Ortega, Craig Bullock
Publikováno v:
Rheumatology. 62
Background/Aims Ixekizumab (IXE) is a high-affinity, monoclonal antibody targeting IL-17A and is approved for the treatment of psoriasis (PsO), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fda2516baafaaf3b7f475948e8b9fb1
https://doi.org/10.1093/rheumatology/kead104.227
https://doi.org/10.1093/rheumatology/kead104.227
Autor:
Antonio Torrelo, Barbara Rewerska, Maria Galimberti, Amy Paller, Chin-Yi Yang, Apurva Prakash, Danting Zhu, Marco Antonio G Pontes Filho, Wen-Shuo Wu, Lawrence F Eichenfield
Publikováno v:
British Journal of Dermatology.
Background Baricitinib, an oral selective Janus kinase (JAK)1/JAK2 inhibitor, is approved in many countries for moderate-to-severe atopic dermatitis (AD) in adults who are candidates for systemic therapy. Objectives To evaluate the efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e92ec9cc95cc59f4162e618d481c9ac
https://doi.org/10.1093/bjd/ljad096
https://doi.org/10.1093/bjd/ljad096
Autor:
Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester
Publikováno v:
Annals of the Rheumatic Diseases. 81:944-950
ObjectivesIxekizumab, a high-affinity monoclonal antibody that selectively targets interleukin 17A (IL-17A), has shown significant efficacy in the treatment of psoriatic arthritis (PsA) and sustained long-term clinical response without unexpected new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a118c8e6f744ca9c71ac68fe1975b8
https://doi.org/10.1136/annrheumdis-2021-222027
https://doi.org/10.1136/annrheumdis-2021-222027